Lagura, Charito C.
HRN: 21-41-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2022
CEFUROXIME 1.5GM (VIAL)
06/02/2022
06/08/2022
IVT
1.5g
Q8hours
T/c Placenta Accreta
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes